滬寧股份(300669.SZ)擬定增募資不超2.99億元 用於緩衝器生產線建設項目等
格隆匯8月31日丨滬寧股份(300669.SZ)發佈2020年度向特定對象發行股票預案,本次向特定對象發行股票數量不超過3331.56萬股(含),發行對象不超過35名(含),為符合中國證監會規定的證券投資基金管理公司、證券公司、信託投資公司、財務公司、保險機構投資者、合格境外機構投資者,以及符合中國證監會規定的其他法人、自然人或其他合格的投資者。
公司本次向特定對象發行股票的募集資金總額不超過2.99億元(含本數),扣除發行費用後,募集資金擬用於年產50萬隻創新型G系列緩衝器生產線建設項目、戰略產品產業化技術系統研發項目、部分產線調整及技術改造建設項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.